Trial intelligence / Profile preview

MDA with SP+AS for Malaria Control in Sudan

NCT00646126Phase 3Completed

Sponsor
Tropical Medicine Research Institute
Start
Aug 2005
Modality
Classical Binding Small Molecules
Countries
1
01

Overview

A Phase 3 trial of sulfadoxine, pyrimethamine, artesunate in Plasmodium falciparum malaria, sponsored by Tropical Medicine Research Institute. Started Aug 2005; status: completed.

02

Drugs

sulfadoxinepyrimethamineartesunate
03

Conditions

Plasmodium falciparum malaria

Beyond the preview

Go deeper on NCT00646126.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00646126.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call